An interventional study of Sunflower oil and Control group in Eczema, sponsored by Oregon Health and Science University. Status unknown at 1 site in United States. Open to participants aged 1 Minute to 6 Months. Per ClinicalTrials.gov, last updated 2011-08-05.
Sponsored by Oregon Health and Science University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 252 studies in Eczema with a site in United States — 34 open to participants now, 48 under way, 9 of them phase 3. Eczema · United States.
Among the 252 studies in Eczema with a site in United States, this one is the 145th largest by enrollment of the 217 interventional ones that give a count, is one of 9 that started in 2010, is one of 46 with no phase, and was the 31st registered.
507 studies on the registry are indexed under Eczema; 91 are open to participants now.
Browse Eczema studies →34 of the 252 studies in Eczema with a site in United States are open now. Recruiting first, the newest first:
Weill Medical College of Cornell University · Sites in United States
Ages 13–17
Arcutis Biotherapeutics, Inc. · Sites in United States
Ages 6+
Pfizer · Sites in United States, Canada, Japan and 1 more country
Ages 12+
Pfizer · Sites in United States, Canada, Japan
Ages 12+
University of California, San Francisco · Sites in United States
Ages 18+ · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 66 Eczema studies recruiting now, 31 (47%) set no upper age limit and 27 (41%) stop at 75 or younger; 35 take children under 18; 22 take healthy volunteers.
This study: 1 Minute to 6 Months · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
252 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 23 · Phase 2 83 · Phase 3 56 · Phase 4 17
First in 2003; this study’s year is marked. 9 started in 2010.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 46 is below the median of 91 across 404 interventional studies indexed under Eczema.
Median enrollment 101 across the 217 interventional studies, 243 across the 34 observational. Of the 182 that completed or were terminated, 111 (61%) have results posted.
This tab as a report to print or save as PDF → With an account.
165 of 252 have an industry lead sponsor. The 10 most frequent:
Oregon Health and Science University is the lead sponsor of 697 studies on the registry; 129 are open to participants now.
Of its 53 completed or terminated interventional studies of FDA-regulated products, 39 (74%) have results posted.
Oregon Health and Science University has 4 studies filed under Eczema — fewer than ten, so there is no comparison to draw.
15 of the studies in Eczema with a site in United States that are under way reach primary completion within a year, 3 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07355075Phase 3Turn TherapeuticsA Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema) | 2027-01-20 |
| NCT06807268Phase 3PfizerA Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema | 2027-05-02 |
| NCT07265479Phase 3Organon and CoA Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis | 2027-08 |
| NCT06928246Daniel KaplanThe Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis | 2026-12-15 |
| NCT06504160National Institute of Allergy and Infectious Diseases (NIAID)Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2) | 2026-12-24 |
Add all 15 to your calendar (.ics) → With an account.
Among the 252 studies in Eczema with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this protocol is to determine the feasibility of doing larger follow-up studies examining whether emollients used from birth can prevent eczema in high-risk babies and to help investigators find out if emollients (moisturizing skin creams) used from birth can prevent eczema in high-risk babies. Hypothesis: Enhancing the skin barrier from birth using emollients will prevent or delay the onset of eczema, especially in predisposed infants.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
One group will be instructed to use a choice of 3 FDA-approved moisturizers and soap substitutes on their newborn infants.
Drug: Sunflower oil · Drug: Aquaphor ointment · Drug: Cetaphil cream
This group will be asked NOT to use any skin moisturizers and use only soap substitutes on their infants.
Drug: Control group
One group will be instructed to use FDA-approved moisturizers and soap substitutes on their newborn infants.
Also known as: Moisturizers
This group will be asked NOT to use any skin moisturizers and use only soap substitutes on their infants.
One group will be instructed to use FDA-approved moisturizers and soap substitutes on their newborn infants.
One group will be instructed to use FDA-approved moisturizers and soap substitutes on their newborn infants.
Proportion of families willing to be randomized.
Determine proportion of families willing to be randomized in order to design larger study in the future.
Time frame: 6 months
Proportion of families eligible for the trial, willing to participate
Time frame: 6 months
Proportion of families who found the interventions acceptable
Time frame: 6 months
Reported adherence with intervention
Time frame: 6 months
Proportion of families for whom the blinding of the assessor to the allocation ostatus was not compromised
Time frame: 6 months
Amount of contamination as a result of increased awareness in the control group
Time frame: 6 months
Percentage of missing data and early withdrawal rates
Time frame: 6 months
Incidence of emollient-related adverse events
Time frame: 6 months
Incidence of eczema at 6 and 12 months
Time frame: 12 months
Age at onset of eczema
Time frame: 6 months
Filaggrin mutation status
Time frame: 6 months
The record gives a start of May 2010, a primary completion of Aug 2011 and a completion of Sep 2012. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jun 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Sunflower Oil · Cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion
Oregon Health and Science University →